Rossmore Private Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $610K | Sell |
25,328
-465
| -2% | -$12.2K | 0.05% | 193 |
|
|
2026
Q1 | $724K | Sell |
25,793
-974
| -4% | -$25.9K | 0.06% | 169 |
|
|
2025
Q4 | $667K | Sell |
26,767
-6,875
| -20% | -$173K | 0.06% | 178 |
|
|
2025
Q3 | $857K | Sell |
33,642
-800
| -2% | -$19.7K | 0.09% | 144 |
|
|
2025
Q2 | $835K | Sell |
34,442
-3,133
| -8% | -$73.1K | 0.1% | 147 |
|
|
2025
Q1 | $952K | Sell |
37,575
-12,360
| -25% | -$323K | 0.12% | 136 |
|
|
2024
Q4 | $1.32M | Sell |
49,935
-8,000
| -14% | -$217K | 0.16% | 103 |
|
|
2024
Q3 | $1.68M | Sell |
57,935
-300
| -0.5% | -$8.75K | 0.21% | 90 |
|
|
2024
Q2 | $1.63M | Sell |
58,235
-750
| -1% | -$20.6K | 0.21% | 88 |
|
|
2024
Q1 | $1.64M | Buy |
58,985
+730
| +1% | +$20.3K | 0.21% | 92 |
|
|
2023
Q4 | $1.68M | Buy |
58,255
+677
| +1% | +$20.5K | 0.24% | 81 |
|
|
2023
Q3 | $1.91M | Sell |
57,578
-112
| -0.2% | -$3.96K | 0.29% | 69 |
|
|
2023
Q2 | $2.12M | Sell |
57,690
-3,925
| -6% | -$153K | 0.31% | 69 |
|
|
2023
Q1 | $2.51M | Buy |
61,615
+536
| +0.9% | +$23.1K | 0.39% | 60 |
|
|
2022
Q4 | $3.13M | Buy |
61,079
+1,917
| +3% | +$91.9K | 0.5% | 49 |
|
|
2022
Q3 | $2.59M | Buy |
59,162
+2,082
| +4% | +$101K | 0.46% | 54 |
|
|
2022
Q2 | $2.99M | Buy |
57,080
+279
| +0.5% | +$14.2K | 0.52% | 50 |
|
|
2022
Q1 | $2.94M | Sell |
56,801
-80
| -0.1% | -$4.15K | 0.46% | 60 |
|
|
2021
Q4 | $3.36M | Buy |
56,881
+1,004
| +2% | +$49.7K | 0.52% | 54 |
|
|
2021
Q3 | $2.4M | Buy |
55,877
+100
| +0.2% | +$4.43K | 0.41% | 63 |
|
|
2021
Q2 | $2.18M | Buy |
55,777
+2,600
| +5% | +$101K | 0.37% | 65 |
|
|
2021
Q1 | $1.93M | Buy |
53,177
+1,000
| +2% | +$35.5K | 0.36% | 68 |
|
|
2020
Q4 | $1.92M | Buy |
52,177
+10,087
| +24% | +$370K | 0.39% | 63 |
|
|
2020
Q3 | $1.47M | Buy |
42,090
+8,002
| +23% | +$281K | 0.34% | 74 |
|
|
2020
Q2 | $1.06M | Buy |
34,088
+11,342
| +50% | +$385K | 0.29% | 74 |
|
|
2020
Q1 | $704K | Buy |
22,746
+14,620
| +180% | +$498K | 0.24% | 88 |
|
|
2019
Q4 | $302K | Hold |
8,126
| – | – | 0.09% | 111 |
|
|
2019
Q3 | $277K | Hold |
8,126
| – | – | 0.09% | 114 |
|
|
2019
Q2 | $334K | Hold |
8,126
| – | – | 0.12% | 102 |
|
|
2019
Q1 | $327K | Sell |
8,126
-1,429
| -15% | -$57.2K | 0.12% | 102 |
|
|
2018
Q4 | $396K | Buy |
9,555
+738
| +8% | +$30.6K | 0.17% | 90 |
|
|
2018
Q3 | $369K | Buy |
8,817
+606
| +7% | +$23.3K | 0.15% | 99 |
|
|
2018
Q2 | $283K | Buy |
8,211
+108
| +1% | +$3.69K | 0.18% | 92 |
|
|
2018
Q1 | $273K | Buy |
8,103
+716
| +10% | +$24.6K | 0.28% | 77 |
|
|
2017
Q4 | $254K | Buy |
+7,387
| New | +$252K | 0.26% | 76 |
|
Other funds holding PFE
Rossmore Private Capital's PFE Position: Q2 2026 in Review
Rossmore Private Capital reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $12.2K and leaving 25,328 shares worth $610K. The position accounts for 0.05% of the portfolio, ranked #193.
Rossmore Private Capital first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.36M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Rossmore Private Capital held 25,328 shares of Pfizer worth $610K as of Q2 2026.
- Rossmore Private Capital sold 465 Pfizer shares in Q2 2026, an estimated $12.2K.
- Pfizer made up 0.05% of Rossmore Private Capital's portfolio in Q2 2026, its #193 holding.
- Rossmore Private Capital first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Rossmore Private Capital's Pfizer position peaked at $3.36M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.